90/014,353CHIMERIC RECEPTOR WITH NKG2D SPECIFICITY FOR USE IN CELL THERAPY AGAINST CANCER AND INFECTIOUS DISEASE9,511,092Closed

Status

Reexamination Certificate Issued

Filed

Aug 2, 2019

Last Updated

Aug 17, 2020

Art Unit

3991

Requester

Unknown

Requester Law Firm

Dz Buschmann Law

Requested By

Third Party

Sector (CPC)

CChemistry & Materials
C12Biotechnology
C12NMicroorganisms & Enzymes

USPC

424Drug, Bio-Affecting And Body Treating Compositions

Reexam History (39 events)

Aug 18, 2020CCRDYApplication ready for PDX access by participating foreign offices
Aug 17, 2020REEXInput Issue Number and Issue Date for Reexamination
Jun 29, 2020RXPUBSReexam Forwarded to Office of Publications
Jun 29, 2020MRNRCRX - Mail Notice of Intent to Issue a Reexam Certificate
Jun 22, 2020PRXRParalegal Reexam Review Complete
Jun 10, 2020RXLITSRReexam Litigation Search Conducted
May 28, 2020RXC/SRCertificate of Service
May 28, 2020RXA...Response after Non-Final Action
Mar 31, 2020MR.NFRX - Mail Reexam Non-Final Action
Feb 19, 2020IDSCInformation Disclosure Statement considered
Feb 19, 2020IDSCInformation Disclosure Statement considered
Feb 19, 2020IDSCInformation Disclosure Statement considered
Nov 15, 2019WIDSInformation Disclosure Statement (IDS) Filed
Nov 15, 2019WIDSInformation Disclosure Statement (IDS) Filed
Nov 15, 2019WIDSInformation Disclosure Statement (IDS) Filed
Nov 15, 2019RXIDS.Information Disclosure Statement Filed
Nov 15, 2019RXFWDXDate Forwarded to Examiner
Nov 15, 2019RXC/SRCertificate of Service
Oct 15, 2019NRX.Notice of Reexam Published in Official Gazette
Sep 9, 2019MREXORX - Mail Ex Parte Request for Reexamination Granted
Aug 26, 2019IDSCInformation Disclosure Statement considered
Aug 20, 2019DOCKCase Docketed to Examiner in GAU
Aug 15, 2019MRXNReexamination Formalities Notice Mailed
Aug 15, 2019MRXNReexamination Formalities Notice Mailed
Aug 14, 2019SMALApplicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27
Aug 14, 2019RXPCOMCompletion of Preprocessing - Released to Assigned GAU
Aug 14, 2019RXNREQFDNotice of reexamination request filing date
Aug 14, 2019RXNREQAUNotice of assignment of reexamination request
Aug 14, 2019MRPWPRX - Mail Pilot Waiver Program - Ex Parte Interview Summary
Aug 13, 2019FTFIFITF set to NO - revise initial setting
Aug 8, 2019RXTTLRPTTitle Report
Aug 5, 2019RXLITSRReexam Litigation Search Conducted
Aug 2, 2019WIDSInformation Disclosure Statement (IDS) Filed
Aug 2, 2019RXOSUB.RReexamination requested by third party requester
Aug 2, 2019RXOSUBReceipt of Original Ex Parte Reexam Request
Aug 2, 2019RXIDS.Information Disclosure Statement Filed
Aug 2, 2019RXC/SRCertificate of Service
Aug 2, 2019RXAF/DRReexam - Affidavit(s), Declaration(s) and/or Exhibit(s) Filed by Third Party Requester
Aug 2, 2019BIG.Entity Status Set To Undiscounted (Initial Default Setting or Status Change)

Prosecution, PTAB & CAFC

PTAB Proceedings (IPR, PGR, CBM, DER)

None found

Federal Circuit (CAFC)

None found

Terminal Disclaimer

None found

Prosecution History

None found

Maintenance Fees

Grant
Dec 6, 2016
3.5-yr
Jun 6, 2020
Paid Jun 8, 2020
7.5-yr
Jun 6, 2024
Paid Jun 6, 2024
11.5-yr
Jun 6, 2028
Expiry
Jul 28, 2035

Entity Status

Large Entity

Expires

Jul 28, 2035 (9.3 yr remaining)

Assignments

Feb 2014Mar 2014Apr 2014May 2014Jun 2014Jul 2014Aug 2014Sep 2014Oct 2014Nov 2014Dec 2014Jan 2015Feb 2015Mar 2015Apr 2015May 2015Jun 2015Jul 2015Aug 2015FiledDARIO CAMPANAYU-HSIANG CHANGST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC.
AssignmentReel/Frame: 038786/0172Recorded: Jun 2, 2016

From

DARIO CAMPANAInventor
Jan 27, 2014
YU-HSIANG CHANGInventor
Jan 27, 2014

To

ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC.